Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Contributed by: Business Wire

Tags

Other Health

Software

General Health

Pharmaceutical

Oncology

Data Management

Technology

Artificial Intelligence

Health Technology

Biotechnology

Neurology

Health

ATLANTIS

More Like This

Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research

K Navigator home screen.

Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare

Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer

Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer

EP2_4 Receptor (Photo: Business Wire)

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology